Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/kdgv-8x75

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Metopirone Treatment in Endogenous Cushing's Syndrome Results from a Prospective Multicenter, Open-Label, Phase III/IV Study: PROMPT

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

One-Year Outcomes of the Open-Label Extension of CHIASMA OPTIMAL, a Phase 3 Study of Oral Octreotide Capsules in Acromegaly
technical paper

One-Year Outcomes of the Open-Label Extension of CHIASMA OPTIMAL, a Phase 3 Study of Oral Octreotide Capsules in Acromegaly

ENDO 2021

21 March 2021

Similar lecture

Hijacking Molecular Plasticity to Fine Tune Nuclear Receptor Signaling
technical paper

Hijacking Molecular Plasticity to Fine Tune Nuclear Receptor Signaling

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved